On August 7, 2019 Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, reported that it will report its financial results for the second quarter ended June 30th, 2019 on Monday August 12th, 2019 after market close (Press release, ProMetic Life Sciences, AUG 7, 2019, View Source [SID1234538331]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Prometic will host a conference call at 11:00 a.m. (EDT) on Tuesday August 13th, 2019. The
telephone numbers to access the conference call are 1-888-231-8191 and 647-427-7450.
An audio replay of the call will be available as of Tuesday August 13th 2019 at 2:00 p.m. (EDT).
The numbers to access the audio replay are 416-849-0833 and 1-855-859-2056 using
the following password: 3058704.
A live audio webcast of the conference call will be available via: